Success Metrics

Clinical Success Rate

100.0%

Based on 12 completed trials

Completion Rate

100%(12/12)

Active Trials

1(8%)

Results Posted

33%(4 trials)

Phase Distribution

Ph phase_1

15%

Ph phase_2

54%

Ph phase_4

31%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution13 total trials

Phase 1Safety & dosage

2(15.4%)

Phase 2Efficacy & side effects

7(53.8%)

Phase 4Post-market surveillance

4(30.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

12 of 12 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(12)

Detailed Status

Completed12

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 12 (15.4%)

Phase 27 (53.8%)

Phase 44 (30.8%)

Trials by Status

recruiting18%

completed1292%

Recent Activity

1 active trials

Showing 5 of 13

recruitingphase_4

Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators

NCT07133880

completedphase_2

Efficacy of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) (CHF 5993)Administered Via Dry Powder Inhaler (DPI) in Chronic Obstructive Pulmonary Disease (COPD)

NCT03590379

completedphase_4

An Open-label Study to Evaluate Correct Use and Ease of Use of the ELLIPTA DPI in Pediatric Subjects With Asthma

NCT03478657

completedphase_2

Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Bipolar Depression

NCT03965871

completedphase_2

Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Depression

NCT03965858

View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials

NCT07133880Phase 4

Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators

Recruiting

NCT03590379Phase 2

Efficacy of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) (CHF 5993)Administered Via Dry Powder Inhaler (DPI) in Chronic Obstructive Pulmonary Disease (COPD)

Completed

NCT03478657Phase 4

An Open-label Study to Evaluate Correct Use and Ease of Use of the ELLIPTA DPI in Pediatric Subjects With Asthma

Completed

NCT03965871Phase 2

Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Bipolar Depression

Completed

NCT03965858Phase 2

Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Depression

Completed

NCT02275052Phase 4

A Study to Evaluate the Effect of the Combination of Umeclidinium (UMEC) and Vilanterol (VI) on Exercise Endurance Time (EET) in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Completed

NCT02567708Phase 2

A Study to Investigate the Efficacy, Safety, and Tolerability of Repeat Doses of Inhaled GSK2269557 in Adults With Persistent, Uncontrolled Asthma

Completed

NCT03407872Phase 1

Safety and Pharmacokinetic Study of Inhaled Esketamine in Healthy Volunteers

Completed

NCT02257372Phase 4

A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Completed

NCT01189396Phase 2

Escalating and Cumulative-Dose Study of Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of A006

Completed

NCT01521377Phase 1

QTc Study GSK573719+GW642444

Completed

NCT01581177Phase 2

Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation

Completed

NCT02210806Phase 2

Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation

Completed

All 13 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 13